Abbott: Abbott's Volt PFA System to treat patients with abnormal heart rhythms receives CE Mark in Europe

Abbott announced it has received CE Mark in Europe for the Volt PFA System to treat patients battling atrial fibrillation (AFib). With the earlier─than─expected CE Mark, Abbott has begun commercial PFA cases in the